GREY:MDCGF - Post by User
Post by
kaiyneon Aug 02, 2010 10:54am
639 Views
Post# 17314954
Top Ten Reasons for an Uptrend
Top Ten Reasons for an Uptrend10. 57,926,423 shares held by institutions, funds, and insiders; 59.29% of O/S.
9. Positive phase 1 results
8. The company will initiate a phase 2 clinical trial in 2010 and results would be available in the fourth quarter of 2010.
7. Vaccine production with Genopole in France.
6. Vaccine development with Ajanta Pharma in India and other territories.
5. Vaccine development with Tabuk in Saudi Arabia and other territories.
4. Commercial vaccine development with NITT Partners in Japan.
3. Development of vaccines with PT BIO FARMA in the Republic of Indonesia.
2. U.S. Army Research, Development and Engineering Command laboratory specifically the Edgewood Chemical Biological Center ("ECBC") Research & Technology Directorate has successfully completed a proof of concept on the affordable production of industrial enzymes in the field of biofuels.
1. Negotiating final terms with D.A.R.P.A. for significant funding to build a state-of-the art plant-based VLP vaccine facility in the U.S.
So the question is, who is going to buy us out six months from now?